Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New scan may sharpen view of head and neck tumors

NCT ID NCT05183048

First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 15 times

Summary

This study compares a new type of PET scan using 89Zr panitumumab with the standard FDG-PET scan to see which one better shows the size and location of head and neck cancers. About 14 newly diagnosed patients will get both scans before surgery. The results are for research only and will not change their treatment plan.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UAB

    RECRUITING

    Birmingham, Alabama, 35249, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.